ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,201.60
1.67%
S&P ASX All Technology
3,829.30
1.67%
Brent Oil
72.225
-0.67%
US Dollar vs AUD
1.60435
0.31%
Bitcoin
95,092.51
-0.02%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV

  6. Aardvark 2 Capital Corp (ACCB.P) Share Price

Aardvark 2 Capital Corp

Aardvark 2 Capital Corp (ACCB.P)

Aardvark 2 Capital Corp
0.09
0.00
(0.00%)
Closed 24 December 8:00AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.09
Bid
0.05
Offer
0.15
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
648k
Previous Close
0.09
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
7,200,000
Dividend Yield
-
PE Ratio
-17.65
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-37k

About Aardvark 2 Capital Corp

Sector
Unit Inv Tr, Closed-end Mgmt
Industry
Unit Inv Tr, Closed-end Mgmt
Headquarters
Toronto, Ontario, Can
Founded
-
Aardvark 2 Capital Corp is listed in the Unit Inv Tr, Closed-end Mgmt sector of the TSX Venture Exchange with ticker ACCB.P. The last closing price for Aardvark 2 Capital was $0.09. Over the last year, Aardvark 2 Capital shares have traded in a share price range of $ 0.00 to $ 0.00.

Aardvark 2 Capital currently has 7,200,000 shares in issue. The market capitalisation of Aardvark 2 Capital is $648,000 . Aardvark 2 Capital has a price to earnings ratio (PE ratio) of -17.65.

Ask ADVFN Intelligence (AI)

ACCB.P Latest News

More News

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - ACCB.P

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - ACCB.P Canada NewsWire VANCOUVER, BC, le 14 juin 2024 VANCOUVER, BC, le 14 juin 2024...

15 June 2024
PR Newswire (Canada)

Canadian Investment Regulatory Organization Trading Halt - ACCB.P

Canadian Investment Regulatory Organization Trading Halt - ACCB.P Canada NewsWire VANCOUVER, BC, June 14, 2024 VANCOUVER, BC, June 14, 2024 /CNW/ - The following issues have been halted by...

15 June 2024
PR Newswire (Canada)

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - ACCB.P

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - ACCB.P Canada NewsWire VANCOUVER, BC, le 28 nov. 2023 VANCOUVER, BC, le 28 nov. 2023...

29 November 2023
PR Newswire (Canada)

Canadian Investment Regulatory Organization Trade Resumption - ACCB.P

Canadian Investment Regulatory Organization Trade Resumption - ACCB.P Canada NewsWire VANCOUVER, BC, Nov. 28, 2023 VANCOUVER, BC, Nov. 28, 2023 /CNW/ - Trading resumes in: Company: Aardvark 2...

29 November 2023
PR Newswire (Canada)

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - ACCB.P

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - ACCB.P Canada NewsWire VANCOUVER, BC, le 13 nov. 2023 VANCOUVER, BC, le 13 nov. 2023...

14 November 2023
PR Newswire (Canada)

Canadian Investment Regulatory Organization Trading Halt - ACCB.P

Canadian Investment Regulatory Organization Trading Halt - ACCB.P Canada NewsWire VANCOUVER, BC, Nov. 13, 2023 VANCOUVER, BC, Nov. 13, 2023 /CNW/ - The following issues have been halted by...

14 November 2023
PR Newswire (Canada)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ACCB.P - Frequently Asked Questions (FAQ)

What is the current Aardvark 2 Capital share price?
The current share price of Aardvark 2 Capital is $ 0.09
How many Aardvark 2 Capital shares are in issue?
Aardvark 2 Capital has 7,200,000 shares in issue
What is the market cap of Aardvark 2 Capital?
The market capitalisation of Aardvark 2 Capital is CAD 648k
What is the 1 year trading range for Aardvark 2 Capital share price?
Aardvark 2 Capital has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Aardvark 2 Capital?
The price to earnings ratio of Aardvark 2 Capital is -17.65
What is the reporting currency for Aardvark 2 Capital?
Aardvark 2 Capital reports financial results in CAD
What is the latest annual profit for Aardvark 2 Capital?
The latest annual profit of Aardvark 2 Capital is CAD -37k
What is the registered address of Aardvark 2 Capital?
The registered address for Aardvark 2 Capital is 77 KING STREET WEST, SUITE 400, TORONTO, ONTARIO, M5K 0A1
Which industry sector does Aardvark 2 Capital operate in?
Aardvark 2 Capital operates in the UNIT INV TR, CLOSED-END MGMT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0

Discussion

View Full Feed
thetinman thetinman 4 minutes ago
Looks like Ptop will deliver the same thing it's delivered to PTOP shareholders for the last 7 years, which is NOTHING and more promises coming with the CEO letter to shareholders next month!! 🤣
PTOP
thesmallguy thesmallguy 4 minutes ago
My response was because I, and a few others, have been waiting over 3 years for a deal here.
ETEK
manibiotech manibiotech 4 minutes ago
Same was said about L 10 years ago . Question is who will be willing to wait another decade 
NWBO
learningcurve2020 learningcurve2020 5 minutes ago
$200,000 plus for a treatment that only shows an alleged 5 year survival advantage beyond SOC in about 5% of patients, and you don't think NICE will have a problem with it?  Unless they can narrow it down to a higher response rate subgroup style="font-size: 1em" that means that about 87% won't respo
NWBO
fredscott36 fredscott36 5 minutes ago
.......OUR - OUR PAYING AGENT............????..................dunno...........

....I was told it was Wilmington Trust.............then......Broadridge, which bought Legent Clearing from Guy.............

.....the BK, our BK cited.............Wellington Management.......
LowFloatLopes LowFloatLopes 5 minutes ago
Christmas Eve eve and your sitting on a board your not invested in? You must have a lot going on in life 😳
NUKK
Cornerstone_Marketing Cornerstone_Marketing 5 minutes ago
https://x.com/adia_nutrition/status/1871185178267410750?s=46&t=ZV-JoM4olm35bFSad3ozrw
ADIA
Paulness Paulness 5 minutes ago
NEWS -- Vivos Inc. Announces Launch of Groundbreaking RadioGel® Precision Radionuclide Therapy™ Human Clinical Trial

https://media.zenfs.com/en/globenewswire.com/596a9a524bfac144adaabea16328ae5b

Richland, WA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- – Vivos Inc. (OTCQB: RDGL)
RDGL
Cornerstone_Marketing Cornerstone_Marketing 6 minutes ago
https://x.com/bult_stock/status/1871186576887419158?s=46&t=ZV-JoM4olm35bFSad3ozrw
BULT
Outcast27 Outcast27 6 minutes ago
Looks like a good one...
ONDS
tw0122 tw0122 6 minutes ago
Just need to cure the chickens lol
TRAW
nathanial nathanial 6 minutes ago
Human trials begin in India without submission of the IDE in USA??? Can someone explain to me what's going on??
RDGL
Monksdream Monksdream 6 minutes ago
Top 15 at 9:00
https://ih.advfn.com/markets/nasdaq/premarket
dstock07734 dstock07734 7 minutes ago
You have plenty of shares? You are trying to be funny, are you not?

If you did own many shares, you would at minimum be inquisitive about the DDs posted by many longs. You are just an upgraded version of marty.
NWBO
chemist72 chemist72 7 minutes ago
... trust nobody, and take zero buying and selling advice from any message board.

Well said.
SMCE
mrkirby mrkirby 7 minutes ago
Most penny stocks aren't worth shorting. It's the rate few that get pounded on. That's a fact. You can sort out your own feelings on that statement..
SAPX
adam123 adam123 7 minutes ago
What is the play today guys? ABAT?
ABAT
CherryTree1 CherryTree1 7 minutes ago
I agree . . . unless they are bought out immediately by a Big Pharma Company why sell with DCVAX - Direct directly behind DCVAX-L.
The revenue potential of Direct is almost unimaginable - Merry Christmas

https://investorshub.advfn.com/uimage/uploads/2022/6/7/nuyvlNWBO_DCVAX_Di
NWBO
trunkmonk trunkmonk 8 minutes ago
well im wont wait for schmuck responses or multiple posts to drown out real events...yeah its coming, and its gonna happen soon I believe, no amount of misguided mayhem will change it.

https://www.msn.com/en-us/money/markets/regret-not-buying-bitcoin-at-10-here-are-3-coins-fighting-fo
XRPUSD
slicknick617 slicknick617 8 minutes ago
This thing going up or down today ?
RGTI
manibiotech manibiotech 8 minutes ago
It won't until they are financially secure . As long as they continue to need money on monthly basis they will be shorted . And folks will keep blaming manipulators . That's just how market works . 
Science is only a part of equation which usual few here find very hard to comprehend 
A
AVXL
vg_future vg_future 8 minutes ago
From the PR, I took this as the second one other than JPAD that was discussed here and ST,

Strengthening the submission is the 265 week (~5-year) Phase 2a trial investigating blarcamesine in mild-to-moderate Alzheimer’s disease, with interim preliminary data published in the peer-rev
AVXL
al44 al44 8 minutes ago
Democrats Don’t Transfer Power Peacefully

By J.B. Shurk


Twenty-four years ago, the Clintons left the White House shamefully. Sixteen years later, Obama framed his successor as a Russian spy and laid the groundwork for a coup d’état. Now Biden is itching for nu
Konaploinks Konaploinks 9 minutes ago
45.90. R t q 😎💰🤙
46.05 9:02 rtq
IONQ
joe_techi joe_techi 10 minutes ago
https://www.reuters.com/markets/mexico-warns-trumps-tariff-would-kill-400000-us-jobs-2024-11-27/
AG

Your Recent History

TSXV
ACCB.P
Aardvark 2 Capital
TG
A3KNZ3
Saipem Finance Internati...
BIT
EQEU
Invesco EQQQ NASDAQ-100 ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads